（原标题：爱尔兰政府发布循环经济战略） 爱尔兰RTE新闻2月25日报道，爱尔兰气候、能源和环境部长达拉赫·奥布莱恩和负责循环经济的国 务部长艾伦·狄龙发布《加速行动》循环经济战略。行动战略确定了建筑业、生物经济、零售业、包装 业、纺织业和电子产品业六个重点领域，今年将陆续发布各分行业路线图。支持地方政府建立再利用、 维修和回收中心，推行全国试点维修券计划，尽可能地重复利用、修理和回收，并在产品和材料报废时 进行再制造。总体目标到2029年实现90%的塑料瓶回收率，到2030年爱循环材料使用率达12%，食物浪 费减少50%，包装废弃物减少5%。 ...

按照产业引领、专班分工、区域联动、精准落地原则，《意见》细化北京、上海、深圳三大驻点专班任 务，实现重点区域与重点产业精准匹配。储能产业依托锂电基础，紧盯固态电池、系统集成、核心装备 等环节；高性能材料立足铝、铜、镁、钛、碳纤维优势，延链发展精深加工与高端复合材料；生物经济 聚焦高原特色资源，打造生物提取、生物医药、医疗器械等；电子信息围绕硅基半导体、新型显示强链 补链；绿色算力以"京数青算"为抓手，对接智算中心、超算中心全链条项目。同时，主动布局低空经 济、氢能、具身智能、光热配套等新赛道，培育新质生产力。 本报西宁讯 （记者 张慧慧） 为主动适应招商引资新形势新挑战，2月9日，西宁（国家级）经济技术开 发区印发《关于进一步加强区域招商专班工作的意见》，以系统化部署、清单化推进、闭环式管理，推 动驻点招商持续发力。 《意见》明确"稳住晶硅、拓展储能、深化有色、壮大生物、算电协同、培育新质"的产业思路，围绕新 能源、新材料、绿色算力、生物经济四大核心赛道，精准招引锻长板、补短板、填空白、强投资的优质 项目，加快构建具有西宁特色与竞争优势的现代化产业体系。并提出量化攻坚目标，即各招商专班全年 对接企业不少于20 ...

Group 1 - The core viewpoint emphasizes the importance of the recent provincial meeting in guiding the development direction of Boli County, focusing on the "eight key efforts" and the development paths of "agriculture-led, industry-strong, green-promoting, and characteristic-rich" [1] Group 2 - Boli County plans to showcase new initiatives and inject new momentum into the revitalization of Heilongjiang by constructing a modern industrial system, with a focus on major projects like the 8.045 billion yuan Jiulong pumped storage power station [2] - The county aims to stabilize grain production at over 1 billion jin while promoting the development of specialty products such as the Boli blue indigo fruit and black sweet grapes, enhancing the local agricultural economy [2] - Key reforms will be implemented to enhance county development vitality, including deepening state-owned enterprise reforms and completing the "management committee + company" reform [2] Group 3 - Environmental improvements will be prioritized, including the upgrade of sewage treatment plants and the restoration of historical mining sites, to ensure compliance with environmental standards [3] - The county will focus on enhancing urban functionality and quality of life through initiatives like the renovation of old neighborhoods and the establishment of community service centers [3] - Efforts will be made to improve public services and social governance, aiming to increase the sense of gain, happiness, and security among residents [3]

Core Viewpoint - The Biotech Economy Index (970038) closed at 2312.84 points, reflecting a 0.68% increase with a trading volume of 47.837 billion yuan and a turnover rate of 3.49% [1] Group 1: Index Performance - On the day, 30 constituent stocks of the Biotech Economy Index experienced gains, with Di'an Diagnostics leading the rise at 11.9% [1] - Conversely, 19 stocks declined, with Meihua Medical showing the largest drop at 6.93% [1] Group 2: Capital Flow - The net inflow of main funds into the Biotech Economy Index constituents totaled 274 million yuan, while speculative funds saw a net outflow of 85.3729 million yuan [2] - Retail investors also experienced a net outflow of 188 million yuan [2]

Group 1 - The core index of the biotechnology sector, the Biotechnology Index (970038), closed at 2297.26 points, reflecting a 1.74% increase with a trading volume of 34.699 billion yuan and a turnover rate of 2.6% [1] - Among the constituent stocks of the Biotechnology Index, 35 stocks experienced an increase, with Dean Diagnostics leading the rise at 19.98%, while 14 stocks saw a decline, with New Industry leading the drop at 3.84% [1] Group 2 - In terms of capital flow, the Biotechnology Index constituents experienced a net outflow of 190 million yuan from major funds, while retail investors saw a net inflow of 286 million yuan [2] - The detailed capital flow indicates that speculative funds had a net outflow of approximately 95.6729 million yuan [2]

Group 1 - The core index of the biotechnology sector, the Biotechnology Index (970038), closed at 2258.05 points, reflecting a 1.64% increase with a trading volume of 30.954 billion yuan and a turnover rate of 2.47% [1] - Among the constituent stocks of the Biotechnology Index, 40 stocks experienced an increase, with Dean Diagnostics leading the rise at a 20.0% increase, while 10 stocks saw a decline, with Meihao Medical leading the drop at an 11.81% decrease [1] Group 2 - In terms of capital flow, the net inflow of main funds into the Biotechnology Index constituents totaled 110 million yuan, while speculative funds saw a net outflow of 416 million yuan, and retail investors had a net inflow of 306 million yuan [2] - Detailed capital flow information for the constituent stocks is available in the accompanying table [2]

Core Viewpoint - Russia is launching a national project in bioeconomy aimed at reducing import dependency and stimulating innovation in biological and chemical technologies, with goals set for 2030 and 2036 [1][4]. Group 1: Project Objectives and Funding - The "Biotechnology Security" project aims to achieve technological sovereignty by 2030 and technological leadership by 2036 through infrastructure development and scientific advancement [1][4]. - The Russian Ministry of Industry and Trade has received over 270 initiatives related to bioeconomy, with 34 projects deemed mature and 72 in early research stages [1][4]. - The project is expected to receive over 20 billion rubles in state funding by 2030, with 5 billion rubles allocated directly from the national budget for 2026-2028 [4][6]. Group 2: Industry Challenges and Solutions - The Russian bioeconomy currently faces significant challenges, including an 80% dependency on imported biotechnology, outdated legislation, and a shortage of talent, particularly in bioenergy and biopharmaceuticals [4][5]. - The national project includes measures to overcome these obstacles, such as investment subsidies and reducing financial burdens [4][5]. - Experts emphasize the need to eliminate restrictions on basic and applied research and improve intergovernmental communication [4][5]. Group 3: Market Potential and Employment - The current market size of Russia's bioeconomy is approximately 440 billion rubles, with projections to grow to 700 billion rubles by 2030 and exceed 1 trillion rubles by 2036 [6]. - The project aims to increase the domestic product market share to 50% and ensure at least 40% of key projects achieve technological independence [6]. - It is expected to create over 15,000 jobs and initiate more than 130 new factories, with performance measured by key indicators such as export growth and investment attraction [6].

Core Insights - The Bioeconomy Index (970038) closed at 2118.88 points, up by 0.65%, with a trading volume of 13.54 billion yuan and a turnover rate of 1.14% [1] - Among the constituent stocks, 41 companies saw an increase, with Pailin Bio leading at a 6.87% rise, while 9 companies experienced a decline, with Muyuan Foods leading the drop at 2.47% [1] - The net outflow of main funds from the Bioeconomy Index constituents totaled 66.18 million yuan, while retail investors saw a net inflow of 166 million yuan [1] Fund Flow Analysis - The Bioeconomy Index constituents experienced a total net outflow of 66.18 million yuan from main funds and 100 million yuan from speculative funds, while retail investors contributed a net inflow of 166 million yuan [1] - Over the past 10 days, the Bioeconomy Index has undergone adjustments, adding 9 new stocks and removing 9 stocks [1]

Core Viewpoint - The Biotech Index (970038) closed at 2071.88 points, down 0.45%, with a trading volume of 13.409 billion yuan and a turnover rate of 1.12% [1] Group 1: Index Performance - On the day, 14 constituent stocks rose, with Furui Co., Ltd. leading with a 4.6% increase, while 36 stocks declined, with Boteng Co., Ltd. leading the decline at 3.86% [1] - The net outflow of main funds from the Biotech Index constituents totaled 445 million yuan, while retail investors saw a net inflow of 578 million yuan [2] Group 2: Constituents Adjustment - In the past 10 days, the Biotech Index constituents underwent adjustments, adding 9 new stocks and removing 9 stocks [2]

Group 1 - The Biotech Economy Index (970038) closed at 2081.32 points, down 1.07%, with a trading volume of 13.004 billion yuan and a turnover rate of 1.18% [1] - Among the constituent stocks, 11 companies saw an increase, with Tiankang Biological leading at a 5.76% rise, while 37 companies experienced a decline, with Boteng Co. leading at a 5.07% drop [1] Group 2 - The Biotech Economy Index constituents experienced a net outflow of 500.1 million yuan from major funds, while retail investors saw a net inflow of 573 million yuan [2] - Over the past 10 days, the Biotech Economy Index has undergone adjustments, adding 9 stocks and removing 9 stocks [2]